Mizuki Tani

Osaka Gakuin University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index782citations63works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(18), Liver Disease Diagnosis and Treatment(9), Microscopic Colitis(6), Alcohol Consumption and Health Effects(5), Blood Pressure and Hypertension Studies(4)

Publications63 total

Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn’s Disease: A Multicenter Prospective Intervention Study
Inflammatory Intestinal Diseases·2025Open Access
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study
Crohn s & Colitis 360·2025· 2 citedOpen Access
Prediction of Positive Angiogram Using Enhanced Computed Tomography in Postpartum Hemorrhage: A Retrospective Multicentered Study
Cureus·2025Open Access
Leucine-rich Alpha-2 glycoprotein could be clinically useful in active and postoperative Crohn’s disease
Scientific Reports·2025· 5 citedOpen Access
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching
Scientific Reports·2025· 1 citedOpen Access
P0323 Serum leucine-rich α2-glycoprotein (LRG) and Monocyte chemoattractant protein-1 (MCP-1) as Novel Biomarkers for Predicting Vedolizumab Response in Ulcerative Colitis Patients
Journal of Crohn s and Colitis·2025
Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease
Scientific Reports·2024· 5 citedOpen Access
Sa1779 USEFULNESS OF SERUM LRG AS A BIOMARKER FOR EVALUATING WHOLE COLONIC INFLAMMATION OF ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE STUDY BY THE OSAKA GUT FORUM
Gastroenterology·2024
Su1804 PRETREATMENT LEVELS OF SERUM LEUCINE-RICH ALPHA-2 GLYCOPROTEIN IS USEFUL FOR SELECTION OF ANTI-CYTOKINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY BY THE OSAKA GUT FORUM
Gastroenterology·2024
EP25 SAFETY AND EFFECTIVENESS OF ORAL BUDESONIDE AFTER ENDOSCOPIC BALLON DILATION FOR INTESTINAL STENOSIS IN PATIENTS WITH CROHN'S DISEASE -A MULTICENTER PROSPECTIVE INTERVENTION STUDY
Gastroenterology·2024
P660 Serum Leucine-rich Alpha-2 Glycoprotein Can be a Biomarker for Selecting Anti-Cytokine Biologics in Patients with Inflammatory Bowel Disease: A Multicentre Prospective Cohort Study
Journal of Crohn s and Colitis·2024Open Access
Carbon dioxide insufflation reduces the relapse of ulcerative colitis after colonoscopy: A randomized controlled trial
PLoS ONE·2023· 1 citedOpen Access
EP144 COMBINATION OF IMMUNOMODULATORS WITH USTEKINUMAB IS A VALUABLE OPTION IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Gastroenterology·2023
Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease
PLoS ONE·2023· 4 citedOpen Access
Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response
The Journal of Experimental Medicine·2022· 38 citedOpen Access
Infantile-Onset Isolated Neurohypophyseal Langerhans Cell Histiocytosis with Central Diabetes Insipidus: A Case Report
Children·2022· 2 citedOpen Access
EP1277: EFFICACY OF CARBON DIOXIDE INSUFFLATION DURING COLONOSCOPY FOR PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION -A RANDOMIZED TRIAL-
Gastroenterology·2022Open Access
Exacerbation of non‐steroidal anti‐inflammatory drug‐induced enteropathy in C‐C chemokine receptor type 7‐deficient mice
Journal of Gastroenterology and Hepatology·2022· 2 citedOpen Access
Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease
Scientific Reports·2022· 17 citedOpen Access
P314 Elderly onset is associated with low efficacy of anti-TNF treatment in Bio-naïve IBD patients: A multicenter cohort study by the Osaka Gut Forum
Journal of Crohn s and Colitis·2022Open Access
page 1 of 4Next →

Frequent Co-authors

Shinichiro Shinzaki(23), Tetsuo Takehara(23), Yuriko Otake(22), Takeo Yoshihara(22), Hideki Iijima(22), Takahiro Amano(21), Yoshito Hayashi(20), Yoshiki Tsujii(19), Yuko Ishizaka(18), Taku Tashiro(18), Minoru Yamakado(17), Takahiro Inoue(16), Akiko Toda(15), Akiko Asakura(12), Satoshi Hiyama(11), Shuko Iwatani(10), Yuko Sakakibara(9), Takuya Yamada(8), Nobukazu Ishizaka(7), Ryotaro Uema(7)